Dr. Caroline Minghwei Kang, MD

Dr. Kang practices at Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health.

Dr. Kang's NPI, 1497142962, was assigned on April 22, 2015. Dr. Kang holds North Carolina license 2022-00802.

Dr. Kang's primary practice is Atrium Health Carolinas Medical Center, at 1000 Blythe Blvd, Charlotte, NC 28203 in Mecklenburg County. The practice phone is (704) 355-2000.

Dr. Kang's primary practice is Atrium Health Carolinas Medical Center in Charlotte, North Carolina, part of Advocate Health. The medical group on file is Atrium Health Cleveland Imaging. Dmand AI also links Dr. Kang to 2 more medical groups and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Kang practices, 2 sites in all. Vendor and product names are available with a free account.

Urology is Dr. Kang's primary specialty in the NPI Registry, under taxonomy code 208800000X. Dr. Kang is licensed in North Carolina.

CMS data shows 22 Medicare services from Dr. Kang across 1 procedure code in 2024, all of them office visits, for 26 Medicare patients. Medicare paid $1,652 for them. Every service was in an office.

CMS counts 26 Medicare patients who saw Dr. Kang in 2024. The largest group is under 65, with 11 patients. 65% of them have high blood pressure, and 65% have high cholesterol. Their average risk score is 2.04, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Kang's median patient age at 39, with 5% women.

In 2024, Dr. Kang wrote 79 Medicare Part D claims for 19 patients. 96% of them were for generic drugs. CMS names the drug for 49 of them, across 1 drug with 11 or more claims each, at $979 in total drug cost. In 2023, CMS named 36 claims across 1 drug.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Kang for performance year 2024, reported as part of a group. Dr. Kang accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Kang as offering telehealth.

Dmand AI links 12 papers to Dr. Kang, published from 2021 to 2024. 2021 was the busiest year, with 4. The most frequent topics are Azoospermia, Spermatozoa and Sperm Retrieval. Dr. Kang has published most often in J Urol. Dr. Kang's most frequent co-authors are James Kashanian, MD, Jessica Ann Marinaro, MD and Aaron Michael Brant, MD.

CMS Open Payments shows 23 general payments to Dr. Kang from 4 drug and device companies from 2021 to 2025. Travel and lodging make up the largest share, 71% of the total. Coloplast Corp paid the most, $1,411.